PPI Dosage Guidelines and Treatment Protocols
Omeprazole Dosage for Acid Reflux
Omeprazole 20mg capsules represent the gold standard for acid reflux treatment in the UK. The standard adult dosage is 20mg once daily, preferably taken 30-60 minutes before breakfast on an empty stomach. This timing ensures optimal absorption and maximum acid suppression when needed most. For severe symptoms, healthcare providers may recommend 40mg daily, though this higher dose should only be used under medical supervision.
Treatment Duration and Maintenance Therapy
Initial treatment courses typically last 4-8 weeks, allowing sufficient time for oesophageal healing and symptom resolution. Many patients experience significant improvement within the first week of treatment. For maintenance therapy, the lowest effective dose is recommended, often 10-20mg daily. Long-term use requires periodic medical review to assess ongoing necessity and monitor for potential side effects.
Alternative PPI Options and Dosing
Lansoprazole 15mg capsules offer an alternative first-line treatment, typically prescribed as 15-30mg once daily. Pantoprazole 20mg tablets provide another option, usually taken as 20-40mg daily. Esomeprazole tablets, often considered the most potent PPI, are typically prescribed at 20-40mg once daily. These medications work similarly to omeprazole but may be preferred in cases of poor initial response or specific patient factors.
H2 Receptor Antagonists: Famotidine Dosing
Famotidine tablets represent an alternative approach for acid reflux management, particularly suitable for patients who cannot tolerate PPIs or require additional acid suppression. The typical dosage ranges from 20-40mg twice daily, taken with or without food. Famotidine may be used as monotherapy for mild-moderate symptoms or in combination with PPIs for refractory cases under specialist guidance.
Factors Affecting Dosage Requirements
Several factors influence optimal dosing for acid reflux medications. Patient weight, age, and severity of symptoms all play important roles in determining appropriate treatment regimens. Concurrent medications may affect PPI absorption or metabolism, potentially requiring dosage adjustments. Lifestyle factors including diet, smoking status, and alcohol consumption can influence treatment effectiveness and may necessitate higher doses or longer treatment durations.
Treatment Response and Dose Optimisation
Most patients experience symptom improvement within 1-2 weeks of starting PPI therapy at standard doses. If symptoms persist after 2-4 weeks, dosage increase or alternative medications may be considered. Some patients require twice-daily dosing for optimal control, typically taking one dose before breakfast and another before the evening meal. Regular monitoring ensures treatment remains effective whilst minimising unnecessary medication exposure.
